Alerts will be sent to your verified email
Verify EmailADLINE
Adline Chem Lab
|
Colinz Laboratories
|
Parmax Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
51.73 % | 4.05 % | -1624.87 % |
5yr average Equity Multiplier
|
0.93 | 1.3 | 46.04 |
5yr Average Asset Turnover Ratio
|
0.25 | 0.7 | 0.95 |
5yr Avg Net Profit Margin
|
15.43 % | 4.66 % | -9.48 % |
Price to Book
|
0.0 | 1.16 | 0.0 |
P/E
|
0.0 | 22.81 | 0.0 |
5yr Avg Cash Conversion Cycle
|
0.0 | -0.66 Days | -161.05 Days |
Inventory Days
|
40.82 Days | 64.79 Days | 73.65 Days |
Days Receivable
|
0.0 | 51.75 Days | 40.27 Days |
Days Payable
|
61.52 Days | 78.66 Days | 328.05 Days |
5yr Average Interest Coverage Ratio
|
10.45 | 9.16 | 1.16 |
5yr Avg ROCE
|
-27.86 % | 6.01 % | -9.94 % |
5yr Avg Operating Profit Margin
|
-8.78 % | 6.82 % | 3.93 % |
5 yr average Debt to Equity
|
-0.21 | 0.07 | 17.42 |
5yr CAGR Net Profit
|
-37.71 % | 30.39 % | n/a |
5yr Average Return on Assets
|
-1534.04 % | 3.14 % | -6.43 % |
Shareholdings
|
|||
Promoter Holding
|
25.85 % | 66.0 % | 30.8 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-4.32 % | -0.01 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Adline Chem Lab
|
Colinz Laboratories
|
Parmax Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|